SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-031042
Filing Date
2019-08-09
Accepted
2019-08-09 08:32:17
Documents
71
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q urgn-10q_20190630.htm   iXBRL 10-Q 2438026
2 EX-31.1 urgn-ex311_7.htm EX-31.1 19231
3 EX-31.2 urgn-ex312_6.htm EX-31.2 19270
4 EX-32.1 urgn-ex321_9.htm EX-32.1 9734
5 EX-32.2 urgn-ex322_8.htm EX-32.2 9752
  Complete submission text file 0001564590-19-031042.txt   7299806

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA urgn-20190630.xsd EX-101.SCH 49505
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE urgn-20190630_cal.xml EX-101.CAL 50550
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE urgn-20190630_def.xml EX-101.DEF 123522
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20190630_lab.xml EX-101.LAB 362504
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20190630_pre.xml EX-101.PRE 270406
11 EXTRACTED XBRL INSTANCE DOCUMENT urgn-10q_20190630_htm.xml XML 1205859
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38079 | Film No.: 191011415
SIC: 2834 Pharmaceutical Preparations